214 related articles for article (PubMed ID: 27862596)
1. Outcome of Patients With Cardiac Sarcoidosis Who Received Cardiac Resynchronization Therapy: Comparison With Dilated Cardiomyopathy Patients.
Yufu K; Kondo H; Shinohara T; Kawano K; Ishii Y; Miyoshi M; Imamura T; Saito S; Okada N; Akioka H; Teshima Y; Nakagawa M; Takahashi N
J Cardiovasc Electrophysiol; 2017 Feb; 28(2):177-181. PubMed ID: 27862596
[TBL] [Abstract][Full Text] [Related]
2. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
[TBL] [Abstract][Full Text] [Related]
3. Early and frequent defibrillator discharge in patients with cardiac sarcoidosis compared with patients with idiopathic dilated cardiomyopathy.
Takaya Y; Kusano K; Nishii N; Nakamura K; Ito H
Int J Cardiol; 2017 Aug; 240():302-306. PubMed ID: 28438355
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy response in cardiac sarcoidosis.
Shabtaie SA; Sehrawat O; Lee JZ; Cha YM; Mulpuru SK; Kowlgi NG; Siontis KC; Rosenbaum AN; Bois JP; AbouEzzeddine OF; Noseworthy PA; Asirvatham SJ; DeSimone CV; Deshmukh AJ
J Cardiovasc Electrophysiol; 2022 Sep; 33(9):2072-2080. PubMed ID: 35870183
[TBL] [Abstract][Full Text] [Related]
5. Effect of Cardiac Resynchronization Therapy on Left Ventricular Remodeling in Patients With Cardiac Sarcoidosis.
Patel D; Trulock KM; Toro S; Grimaldi A; Gonzalez M; Moennich LA; Gorodeski EZ; Joyce E; Niebauer M; Wilkoff BL; Varma N; Rickard JW
Am J Cardiol; 2019 Jan; 123(2):329-333. PubMed ID: 30471710
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
[TBL] [Abstract][Full Text] [Related]
7. A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.
Martinelli Filho M; de Lima Peixoto G; de Siqueira SF; Martins SAM; Nishioka SAD; Pedrosa AAA; Teixeira RA; Dos Santos JX; Costa R; Kalil Filho R; Ramires JAF
Europace; 2018 Nov; 20(11):1813-1818. PubMed ID: 29509903
[TBL] [Abstract][Full Text] [Related]
8. Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.
Darma A; Nedios S; Kosiuk J; Richter S; Doering M; Arya A; Rolf S; Sommer P; Hindricks G; Bollmann A
Europace; 2016 Mar; 18(3):405-12. PubMed ID: 26056190
[TBL] [Abstract][Full Text] [Related]
9. The clinical outcome of cardiac resynchronization therapy in post-surgical valvular cardiomyopathy.
Leyva F; Umar F; Taylor RJ; Steeds RP; Frenneaux MP
Europace; 2016 May; 18(5):732-8. PubMed ID: 26802014
[TBL] [Abstract][Full Text] [Related]
10. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
[TBL] [Abstract][Full Text] [Related]
11. Fragmented QRS Is a Novel Risk Factor for Ventricular Arrhythmic Events After Receiving Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy.
Igarashi M; Tada H; Yamasaki H; Kuroki K; Ishizu T; Seo Y; Machino T; Murakoshi N; Sekiguchi Y; Noguchi Y; Nogami A; Aonuma K
J Cardiovasc Electrophysiol; 2017 Mar; 28(3):327-335. PubMed ID: 27925329
[TBL] [Abstract][Full Text] [Related]
12. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
[TBL] [Abstract][Full Text] [Related]
13. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.
Fussner LA; Karlstedt E; Hodge DO; Fine NM; Kalra S; Carmona EM; Utz JP; Isaac DL; Cooper LT
Eur J Heart Fail; 2018 Dec; 20(12):1713-1720. PubMed ID: 30378224
[TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronization therapy for patients with cardiac sarcoidosis.
Sairaku A; Yoshida Y; Nakano Y; Hirayama H; Maeda M; Hashimoto H; Kihara Y
Europace; 2017 May; 19(5):824-830. PubMed ID: 28339577
[TBL] [Abstract][Full Text] [Related]
15. A new score system for predicting response to cardiac resynchronization therapy.
Kang Y; Cheng L; Cui J; Li L; Qin S; Su Y; Mao J; Gong X; Chen H; Pan C; Shen X; He B; Shu X
Cardiol J; 2015; 22(2):179-87. PubMed ID: 25428735
[TBL] [Abstract][Full Text] [Related]
16. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Sarcoidosis, Left Ventricular Impairment and Chronic Right Ventricular Pacing: Pacing or Pathology?
Forotan H; Rowe MK; Korczyk D; Kaye G
Heart Lung Circ; 2017 Nov; 26(11):1175-1182. PubMed ID: 28652030
[TBL] [Abstract][Full Text] [Related]
18. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.
de Sisti A; Toussaint JF; Lavergne T; Ollitrault J; Abergel E; Paziaud O; Ait Said M; Sader R; LE Heuzey JY; Guize L
Pacing Clin Electrophysiol; 2005 Dec; 28(12):1260-70. PubMed ID: 16403157
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.
Leyva F; Taylor RJ; Foley PW; Umar F; Mulligan LJ; Patel K; Stegemann B; Haddad T; Smith RE; Prasad SK
J Am Coll Cardiol; 2012 Oct; 60(17):1659-67. PubMed ID: 23021326
[TBL] [Abstract][Full Text] [Related]
20. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
